Recombinant Mouse ADP-ribosyl cyclase 1 (Cd38)

What is mouse CD38 and how does it function as an ADP-ribosyl cyclase?

Mouse CD38 is a 45-kD transmembrane glycoprotein that functions as a multifunctional enzyme capable of catalyzing the cyclization of NAD+ to cyclic ADP-ribose (cADPR). It possesses both enzymatic and receptor functions, with its enzymatic activity primarily involving the conversion of NAD+ to cADPR, which then acts as a signaling molecule that gates calcium release through ryanodine receptors. The protein has a short cytoplasmic tail without tyrosine residues or identified activation motifs . CD38 also functions as a receptor that can mediate cell-to-cell interactions by binding to its ligand, CD31 (PECAM-1), thereby participating in diverse cellular signaling pathways beyond its enzymatic functions .

How does CD38 contribute to calcium signaling pathways in mouse cells?

CD38 plays a crucial role in calcium signaling through its enzymatic production of cADPR, which serves as a second messenger that activates ryanodine receptors (RyRs). In various cell types such as osteoclasts, CD38 activation by an agonist antibody in the presence of NAD+ triggers a cytosolic Ca2+ signal that can be markedly attenuated by ryanodine receptor modulators such as ryanodine and caffeine . This CD38-mediated calcium signaling pathway is essential for numerous cellular processes including bone resorption, synaptic transmission, and immune cell function. The CD38/cADPR system effectively couples cellular metabolic activity to calcium-dependent functions, acting as a sensor for NAD+ levels and converting this information into calcium signals .

What evidence supports the existence of CD38-independent ADP-ribosyl cyclase in mouse tissues?

Multiple lines of evidence support the existence of CD38-independent ADP-ribosyl cyclase activity in mouse tissues, particularly in the brain. Studies have shown that the endogenous level of cADPR in adult brain tissue from CD38 knockout (Cd38−/−) mice is not significantly different from that of wild-type mice, indicating the presence of alternative cyclase activity . Specifically, brain homogenates from Cd38−/− mice maintain cADPR content of approximately 3.0±0.8 pmol/mg, which is similar to values found in wild-type mice . Furthermore, researchers have directly observed significant ADP-ribosyl cyclase activity in synaptosomes isolated from Cd38−/− mouse brains, with the highest activities detected in preparations from neonatal animals compared to adults .

What are the distinctive properties of the CD38-independent ADP-ribosyl cyclase?

The CD38-independent ADP-ribosyl cyclase found in mouse brain tissues exhibits several distinctive properties:

• High sensitivity to zinc: It is fully inhibited by low (micromolar) concentrations of zinc, unlike CD38 from HL-60 cells which is stimulated by zinc .

• Developmental regulation: Higher activity is observed in neonatal brain synaptosomes compared to adult preparations, consistent with the finding that endogenous brain cADPR content is higher during development .

• Subcellular localization: This novel cyclase is particularly enriched in synaptic terminals, suggesting a specific role in synaptic transmission .

• Functional significance: The enzyme is proposed to regulate the production of cADPR and therefore calcium levels within brain synaptic terminals, potentially serving as a relay between extracellular signals and intracellular calcium-dependent events .

What are the optimal methods for measuring CD38 enzymatic activity in mouse tissues?

Several methodological approaches can be employed to measure CD38 ADP-ribosyl cyclase activity in mouse tissues:

• Cycling assay: This highly sensitive method developed by Graeff and Lee accurately measures cADPR content in tissue homogenates. Using this technique, researchers have determined cADPR levels in various mouse brain regions as shown in Table 1 .

• NGD+ assay: This method utilizes nicotinamide guanine dinucleotide (NGD+, a surrogate of NAD+) which is converted by ADP-ribosyl cyclase to its fluorescent derivative cGDP-ribose, allowing for straightforward detection of enzymatic activity .

• Calcium release bioassay: This functional approach measures the calcium-mobilizing activity of cADPR produced by CD38 .

• Radioimmunoassay (RIA): Provides quantitative measurement of cADPR content in tissues .

Table 1: cADPR Content in Mouse Brain Tissues

How can researchers distinguish between CD38-dependent and CD38-independent ADP-ribosyl cyclase activities?

Researchers can differentiate between these two sources of cyclase activity through several strategies:

• Genetic models: Using CD38 knockout mice (Cd38−/−) allows direct study of CD38-independent cyclase activity. Comparing enzyme activities and cADPR levels between wild-type and knockout tissues reveals the contribution of each pathway .

• Differential inhibitor sensitivity: The CD38-independent cyclase from mouse brain is inhibited by micromolar concentrations of zinc, while CD38 from other sources is stimulated by zinc. This contrasting response provides a useful tool for distinguishing the two types of cyclase activities .

• Antibody studies: Preincubation with anti-CD38 antibodies increases ADPR-cyclase activity in CD38-expressing HL-60 cells but not in some vascular smooth muscle cells despite their CD38 expression, helping to identify the source of cyclase activity .

• Substrate specificity analysis: Examining the ability of the enzyme to process different NAD+ analogs can help distinguish CD38 from other cyclases .

Table 2: Effects of Zinc on Different ADP-Ribosyl Cyclases

How does CD38 contribute to brain development and synaptic function?

CD38 and related ADP-ribosyl cyclases play significant roles in brain development and synaptic function:

• Developmental regulation: Endogenous brain cADPR content and novel ADP-ribosyl cyclase activity are higher in the developing brain and decline in adult tissue, suggesting important roles during neurodevelopment .

• Synaptic calcium regulation: The CD38-independent ADP-ribosyl cyclase is proposed to participate in the production of cADPR within nerve terminals, thereby regulating calcium-dependent pathways crucial for synaptic transmission .

• Response to metabotropic receptor activation: cADPR production occurs following activation of metabotropic receptors in several neural cell types and is involved in various neural processes at synaptic connections .

• Zinc sensitivity: The novel cyclase's sensitivity to micromolar concentrations of zinc may link it to zinc-mediated neuromodulation, as zinc is known to modulate synaptic activities. Imbalances in zinc homeostasis can generate brain injury and cognitive development defects, suggesting the cyclase might be a target of neurotoxic zinc .

What is the role of CD38 in B cell receptor signaling and immune function?

CD38 serves critical functions in B cell receptor (BCR) signaling and broader immune processes:

• BCR coreceptor function: CD38 is a member of the IgM-BCR coreceptor complex, associating with CD19 in unstimulated B cells and with both CD19 and IgM upon engagement .

• Regulation of B cell activation: Targeting CD38 with an antibody or removing it with CRISPR/Cas9 inhibits the association of CD19 with the IgM-BCR, impairing BCR signaling in both normal and malignant B cells .

• Marker of cellular activation: In chronic lymphocytic leukemia (CLL), CD38 expression labels an activated subset of leukemic cells. Studies demonstrate a direct relationship between the expression of the cell cycle marker Ki-67 and the density of CD38 on CLL cells, with higher CD38 expression correlating with increased Ki-67 positivity .

• Immunomodulatory functions: CD38 acts as an immunomodulatory molecule in inflammation, affecting various immune cell functions through both its enzymatic activities and receptor functions .

Which amino acid residues are critical for mouse CD38 enzymatic activity?

Site-directed mutagenesis studies have identified several critical residues for CD38 enzymatic function:

Table 3: Critical Residues for CD38 Enzymatic Activity

These findings provide crucial insights for researchers seeking to engineer variants of recombinant mouse CD38 with modified enzymatic properties. For instance, mutations at E146 and T221 can be utilized to create CD38 variants with enhanced cADPR synthesis capabilities for studies requiring increased calcium signaling, while E226 mutations can generate catalytically inactive variants for use as controls or to study receptor functions independently of enzymatic activity .

What factors regulate CD38 expression and activity in mouse tissues?

Multiple factors have been identified that regulate CD38 expression and enzymatic activity:

Table 4: Factors that Regulate ADP-Ribosyl Cyclase Activity

Additionally, inflammatory mediators can modulate CD38 expression in certain contexts, consistent with its role as an immunomodulatory molecule . The stimulatory effect of atRA is blocked by actinomycin D and cycloheximide, indicating regulation at the transcriptional and translational levels . These regulatory mechanisms provide multiple targets for experimental manipulation of CD38 activity in research settings.

How can membrane orientation of CD38 be manipulated for research purposes?

CD38 can adopt different membrane orientations that significantly affect its function:

• Type II orientation: The C-terminal catalytic domain faces the extracellular space, allowing CD38 to act primarily on extracellular NAD+.

• Type III orientation: The catalytic domain faces the cytoplasm, enabling CD38 to metabolize intracellular NAD+ and generate cADPR within the cell .

Researchers can manipulate CD38 orientation through several approaches:

• Engineering chimeric proteins with different transmembrane domains to favor specific orientations

• Creating soluble forms of CD38 that lack transmembrane regions entirely, which has been shown to maintain enzymatic activity and produce intracellular cADPR using cytosolic NAD+ as substrate

• Using cell-type specific expression systems that naturally favor one orientation over another

• Employing mutations that affect protein folding or membrane insertion to alter the distribution between type II and type III orientations

Understanding and manipulating CD38 orientation allows researchers to specifically target either extracellular or intracellular NAD+ pools and their downstream signaling pathways.

What are the implications of the zinc sensitivity of the CD38-independent ADP-ribosyl cyclase for neurological research?

The zinc sensitivity of the CD38-independent ADP-ribosyl cyclase has significant implications for neurological research:

• Zinc as a neuromodulator: The inhibition of this cyclase by micromolar concentrations of zinc may represent a physiologically relevant regulatory mechanism, as zinc is known to modulate synaptic activities . This connection provides a potential link between zinc signaling and calcium regulation in neural tissues.

• Neurotoxicity mechanisms: Since imbalances in zinc homeostasis can generate brain injury and defects in cognitive development, the cyclase might be a target of neurotoxic zinc . This suggests a potential mechanism by which zinc dysregulation could impair calcium signaling and contribute to neurological disorders.

• Developmental neurobiology: The higher activity of this cyclase in neonatal versus adult brain, combined with its zinc sensitivity, suggests a potential role in developmental processes that might be modulated by changing zinc concentrations during brain development .

• Therapeutic target: The distinct pharmacological profile of this cyclase, particularly its zinc sensitivity, offers potential for selective targeting in neurological conditions where calcium dysregulation plays a role.

• Experimental tool: The differential sensitivity to zinc between CD38 and the CD38-independent cyclase provides researchers with a valuable tool to distinguish between these enzymatic activities in neurological research .